The combination of IGF-2 + 3580 AA genotype and IGF-2R GG genotype may be associated with a significantly lower risk of HCC (OR = 0.20, 95% CI = 0.05–0.87). This evidence concerns the gene IGF2 and hepatocellular carcinoma.